Transfusion practice for patients with sickle cell disease.

Area of Science:

• Hematology
• Transfusion Medicine
• Pediatric Hematology

Background:

• Sickle cell disease management is evolving with increased patient survival.
• Longer lifespans lead to a higher incidence of chronic systemic complications.
• Erythrocyte transfusions are crucial for managing both acute and chronic sickle cell disease issues.

Purpose of the Study:

• To review the changing landscape of erythrocyte transfusion practices in sickle cell disease.
• To highlight the benefits of transfusions in managing complications and improving longevity.
• To discuss the risks and emerging alternative therapies relevant to sickle cell disease patients.

Main Methods:

• Literature review of current transfusion practices for sickle cell disease.
• Analysis of the benefits and risks associated with repetitive erythrocyte transfusions.
• Exploration of novel therapeutic approaches, including alternative oxygen carriers.

Main Results:

• Transfusions effectively treat numerous acute and chronic complications in sickle cell disease.
• Increased patient longevity due to improved care results in greater prevalence of chronic conditions.
• Key risks include immunologic phenomena, hemosiderosis, and transfusion-transmitted infections.

Conclusions:

• Erythrocyte transfusion remains a cornerstone therapy for sickle cell disease, addressing diverse complications.
• Proactive and preventive transfusion strategies are increasingly considered for specific patient groups.
• Ongoing research into alternative oxygen carriers and erythrocyte modification offers future therapeutic promise.